大華繼顯:升比亞迪(1211.HK)目標至180港元 維持買入評級
大華繼顯發表研究報告指,中國將實施電動車2021-35年的計劃,通過有利的政策和完善的充電基礎設施,料到2025年和2035年電動車分別佔新車銷量的25%和50%。
該行對電動車行業維持增持評級,將比亞迪(1211.HK)股目標價由150港元上調至180港元,維持買入評級,並將其2021至22年盈利預測分別調升5%及11%,至57億及75億元人民幣,以反映電動車及電池銷售上升。
另外,該行將寧德時代(300750.SZ)目標價由250元人民幣上調至320元人民幣,維持買入評級。
該行指,將中國2025年電動車銷量預測上調19%至525萬輛,2021-25年的複合年增長率為36%,相信中國政府未來會推出大量政策去加快電動車銷售。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.